Davies, Rhian Siān <br/><br/>
What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?  [electronic resource] 

 -  Anticancer research  Oct 2015 
 - 5615-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--therapeutic use<br/>Androstenes--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Retrospective Studies<br/>Survival Rate